Form 4: Hayward Holdings CEO Holleran Exercises Options and Sells Shares

Sentiment:

SEC Form 4 Filing


Kevin Holleran, President and CEO of Hayward Holdings, exercised stock options and sold 100,000 shares of common stock on November 11, 2024.

Summary

  • On November 11, 2024, Kevin Holleran, the President and CEO of Hayward Holdings, exercised stock options to acquire 100,000 shares of common stock at a price of $1.40 per share.
  • Simultaneously, Holleran sold 100,000 shares of Hayward Holdings common stock at a weighted average price of $15.9617, with individual sales ranging from $15.83 to $16.17.
  • Following these transactions, Holleran directly owns 522,799 shares of Hayward Holdings common stock.
  • He also indirectly owns 700 shares each through Child A, Child B, and Child C.
  • Holleran continues to hold options to purchase 3,238,571 shares of common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as it reports routine stock transactions by an executive. The exercising of options and subsequent sale of shares is a common practice.

Industry Context

Executive stock transactions are common and closely watched by investors as they can provide insights into management's perspective on the company's valuation and future prospects. It's important to consider the overall context, including the executive's compensation structure and the company's performance.

Comparison to Industry Standards

  • Executive stock sales are a normal part of corporate compensation.
  • Comparing Holleran's transactions to those of CEOs at similar companies (e.g., Pentair, Pool Corporation) would provide a better understanding of whether these actions are typical or unusual.
  • Factors to consider include the size of the sale relative to total holdings, the timing of the sale in relation to company performance, and any stated reasons for the transaction.

Stakeholder Impact

  • The sale of shares by the CEO could have a minor impact on shareholder sentiment, depending on how the market interprets the transaction.
  • The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
08/12/2021Date stock options became exercisable
11/11/2024Date of transaction: Exercise of stock options and sale of shares
11/12/2024Date of signature on the form
12/24/2029Expiration date of stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.